Hospital and community program to prevent repeat firearm violence among survivors in Central Arkansas.
Official title: The HVIP+ Community Model: A Community Violence Prevention Program in a Southern State
Run by University of Arkansas · NCT07539142 · Data updated 2026-11-12
This trial will try a coordinated program of bedside counseling, peer support, case management with vouchers, and group therapy to see if it reduces repeat firearm injuries among adults treated for gunshot wounds in Central Arkansas.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 208 (estimated) |
| Sponsor | University of Arkansas Academic / other |
| Locations | 1 site (Little Rock, Arkansas) |
| Status | Recruiting |
| Started | April 20, 2026 |
| Main results expected | June 2028 |
| Study ends | June 2028 |
| Registry record updated | June 2, 2026 |
| Trial ID | NCT07539142 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults aged 18 or older who live in Central Arkansas and are currently being treated at a local hospital for a penetrating gunshot injury, who can consent and are not in police custody.
✕Probably not a fit
People with active intoxication, severe cognitive impairment or psychosis, those currently under arrest or in custody, or individuals who live outside Central Arkansas are unlikely to benefit from or be eligible for this program.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This optimization randomized controlled trial will test a multi-level Hospital-based Violence Intervention Program (HVIP) delivered through hospital-community partnerships in Central Arkansas. The intervention package includes brief bedside engagement, peer support, intensive case management with vouchers, and SELF group therapy sessions. Adults treated for penetrating gun assault injuries at local hospitals will be enrolled and randomized to different optimized component combinations while the study measures preliminary effects on repeat violence. Implementation science measures will be collected to evaluate feasibility, reach, and potential for broader rollout.
Why it matters
Potential benefit: If successful, the program could lower the risk of repeat firearm injury and better connect survivors to community services and supports.
How similar studies have gone: Previous hospital-based violence intervention programs have shown promising but mixed results in reducing reinjury and criminal justice outcomes, and this optimization trial applies a novel multi-level, community-partnered approach.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Be at least 18 years of age or older * Currently live in Central Arkansas * Currently being treated for a penetrating gun assault injury at a local hospital Exclusion Criteria: Participants must not: * Report any medical problems that would limit their ability to express thoughts and answer questions (i.e. active intoxication, developmental delays, dementia, psychosis, etc.) * Be currently under arrest or in police custody
Where it's running
-
University of Arkansas for Medical Sciences
Little Rock, Arkansas, United States Recruiting
Study contacts
- Principal investigator: Nakita Lovelady, PhD, MPH — University of Arkansas
- Study coordinator: Nakita Lovelady, PhD, MPH
- Email: nnlovelady@uams.edu
- Phone: 501-526-6731
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Ticagrelor to See if Inflammation Drops in CKD Patients
In adults with chronic kidney disease, this study tests whether ticagrelor can reduce inflammation compared with a placebo.
-
Perinatal PTSD in moms in Arkansas: See if Written Exposure Therapy helps via telehealth
This study tests whether a brief telehealth PTSD therapy called Written Exposure Therapy can be feasibly offered to pregnant or recent-partum individuals in substance-use care in Arkansas.
-
How Different Levels of CPAP Deliver Oxygen to Preterm Babies
This study tests how much oxygen actually reaches preterm infants when they receive nasal CPAP at different air pressures.
-
Intratumoral MMR Vaccine Injection for Borderline Unresectable Pancreatic Cancer
This study tests whether injecting the MMR vaccine directly into a pancreatic tumor can shrink tumors that can’t be surgically removed after standard therapy.
-
Improving supervision in addiction treatment programs
This project will try a reinforcement-based supervision approach with supervisors and counselors at residential addiction treatment programs to see if it reduces counselor burnout and improves care for clients.
-
AI-guided biopsy approach for detecting prostate cancer with indeterminate or low-risk MRI findings
We test if an AI-informed biopsy approach helps find significant prostate cancer in men with indeterminate or low-risk MRI results and elevated PSA.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.